What does Apotheek St.-Job do?

Apotheek St.-Job is a pharmacy in Schoten. Private Limited, started on 11 December 1984, 2 establishments.

What is the address of Apotheek St.-Job?

The registered office of Apotheek St.-Job is located at Sint-Benedictusdreef 10, 2900 Schoten.

Is Apotheek St.-Job still active?

Yes. According to the CBE (29 October 2026) Apotheek St.-Job is active, legal situation “Normale toestand”, started on 11 December 1984.

Is Apotheek St.-Job registered on Peppol?

Yes, Apotheek St.-Job is registered on the Peppol network with ID 0208:0426532853.

What is the enterprise number of Apotheek St.-Job?

The enterprise number of Apotheek St.-Job is BE0426532853.

When was Apotheek St.-Job founded?

Apotheek St.-Job was founded on 11 December 1984.

Who are the directors of Apotheek St.-Job?

According to the 2025 annual accounts, the directors of Apotheek St.-Job are: Solmé Pharma BV.

Is Apotheek St.-Job a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 December 1984; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Apotheek St.-Job make in 2025?

Apotheek St.-Job recorded a loss after taxes of € 22,430 in financial year 2025.

What is the revenue of Apotheek St.-Job?

As a small company, Apotheek St.-Job is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 577,118.

How much does an employee at Apotheek St.-Job earn?

The average wage cost per full-time employee at Apotheek St.-Job was € 67,100 in 2025: staff costs of € 402,510 for 6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek St.-Job have?

According to the 2025 annual accounts, Apotheek St.-Job has 6 full-time equivalents (FTE).

Apotheek St.-Job (Private Limited) - Schoten

Dossier Apotheek St.-Job, printed on 29 October 2026 from databakkes.be/en/0426532853/apotheek-st-job. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 34 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Apotheek St.-Job from Schoten, company number BE0426532853, closed financial year 2025 with a result of € -22,430 after tax. For that financial year Apotheek St.-Job recorded a gross margin of € 577,118 and equity of € 949,485. Compared with financial year 2024, the result moved from € -12,397 to € -22,430. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Healthy

€ 949,485

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -22,430

▼ 81 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 81,521

▼ 45% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 930,885.

People and assets in 2025

Full-time equivalents

▲ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 402,510

▲ 20% vs 2024

€ 67,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 55,914

▲ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 735,667

▼ 10% vs 2024

€ 89,069 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 137,339

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 68,946

▲ 34% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 438,338 Gross margin 2022: € 438,338 First fiscal year in the series	€ 464,581 Gross margin 2023: € 464,581 ▲ 6% vs 2022 (€ 438,338) Favourable step	€ 457,275 Gross margin 2024: € 457,275 ▼ 2% vs 2023 (€ 464,581) Unfavourable step	€ 577,118 Gross margin 2025: € 577,118 ▲ 26% vs 2024 (€ 457,275) Favourable step	▲ 26%
Profit after taxes	€ 20,705 Profit after taxes 2022: € 20,705 First fiscal year in the series	€ 81,451 Profit after taxes 2023: € 81,451 ▲ 293% vs 2022 (€ 20,705) Favourable step	€ -12,397 Profit after taxes 2024: € -12,397 ▼ € 93,848 vs 2023 (€ 81,451) Unfavourable step	€ -22,430 Profit after taxes 2025: € -22,430 ▼ € 10,032 vs 2024 (€ -12,397) Unfavourable step	▼ € 10,032
Equity	€ 902,861 Equity 2022: € 902,861 First fiscal year in the series	€ 984,312 Equity 2023: € 984,312 ▲ 9% vs 2022 (€ 902,861) Favourable step	€ 971,915 Equity 2024: € 971,915 ▼ 1% vs 2023 (€ 984,312) Unfavourable step	€ 949,485 Equity 2025: € 949,485 ▼ 2% vs 2024 (€ 971,915) Unfavourable step	▼ 2%
Total debts	€ 977,124 Total debts 2022: € 977,124 First fiscal year in the series	€ 928,627 Total debts 2023: € 928,627 ▼ 5% vs 2022 (€ 977,124) Favourable step	€ 1,483,584 Total debts 2024: € 1,483,584 ▲ 60% vs 2023 (€ 928,627) Unfavourable step	€ 1,618,575 Total debts 2025: € 1,618,575 ▲ 9% vs 2024 (€ 1,483,584) Unfavourable step	▲ 9%
Cash	€ 91,965 Cash 2022: € 91,965 First fiscal year in the series	€ 112,913 Cash 2023: € 112,913 ▲ 23% vs 2022 (€ 91,965) Favourable step	€ 148,198 Cash 2024: € 148,198 ▲ 31% vs 2023 (€ 112,913) Favourable step	€ 81,521 Cash 2025: € 81,521 ▼ 45% vs 2024 (€ 148,198) Unfavourable step	▼ 45%
Land & buildings	€ 1,568,776 Land & buildings 2022: € 1,568,776 First fiscal year in the series	€ 1,503,782 Land & buildings 2023: € 1,503,782 ▼ 4% vs 2022 (€ 1,568,776) Unchanged	€ 1,443,453 Land & buildings 2024: € 1,443,453 ▼ 4% vs 2023 (€ 1,503,782) Unchanged	€ 1,396,986 Land & buildings 2025: € 1,396,986 ▼ 3% vs 2024 (€ 1,443,453) Unchanged	▼ 3%
Retained profit	€ 884,261 Retained profit 2022: € 884,261 First fiscal year in the series	€ 965,712 Retained profit 2023: € 965,712 ▲ 9% vs 2022 (€ 884,261) Favourable step	€ 953,315 Retained profit 2024: € 953,315 ▼ 1% vs 2023 (€ 965,712) Unfavourable step	€ 930,885 Retained profit 2025: € 930,885 ▼ 2% vs 2024 (€ 953,315) Unfavourable step	▼ 2%
Bank debt	€ 829,780 Bank debt 2022: € 829,780 First fiscal year in the series	€ 430,604 Bank debt 2023: € 430,604 ▼ 48% vs 2022 (€ 829,780) Favourable step	€ 813,379 Bank debt 2024: € 813,379 ▲ 89% vs 2023 (€ 430,604) Unfavourable step	€ 735,667 Bank debt 2025: € 735,667 ▼ 10% vs 2024 (€ 813,379) Favourable step	▼ 10%
Balance sheet total	€ 2,072,157 Balance sheet total 2022: € 2,072,157 First fiscal year in the series	€ 2,039,086 Balance sheet total 2023: € 2,039,086 ▼ 2% vs 2022 (€ 2,072,157) Unchanged	€ 2,574,844 Balance sheet total 2024: € 2,574,844 ▲ 26% vs 2023 (€ 2,039,086) Unchanged	€ 2,680,604 Balance sheet total 2025: € 2,680,604 ▲ 4% vs 2024 (€ 2,574,844) Unchanged	▲ 4%
Employees (FTE)	5.4 Employees (FTE) 2022: 5.4 First fiscal year in the series	5.2 Employees (FTE) 2023: 5.2 ▼ 0.2 vs 2022 (5.4) Unchanged	5.4 Employees (FTE) 2024: 5.4 ▲ 0.2 vs 2023 (5.2) Unchanged	6 Employees (FTE) 2025: 6 ▲ 0.6 vs 2024 (5.4) Unchanged	▲ 0.6

Key figures of Apotheek St.-Job, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek St.-Job?

What happened at Apotheek St.-Job in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: loss of € 22,430. filed late Source: NBB ↗
Nov 13, 2024 New establishment in Brecht. KBO
2014 Solmé Pharma BV became a director. NBB
Jan 1, 1985 New establishment in Brecht. KBO
Dec 11, 1984 Start of the company according to the CBE. KBO

In short

From € 20,705 profit in 2022 to € 22,430 loss in 2025.

Paid € 31,604 in corporate taxes since 2022.

Best year ever: 2023, with € 81,451 profit.

On average € 96,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

SOLME PHARMA 93.3%

The stake of SOLME PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek St.-Job

Thuizorg Cooperatie 0%

Behind Apotheek St.-Job is Solmé Pharma BV. The shares are held by SOLME PHARMA (93.3%). It owns 0% of Thuizorg Cooperatie itself.

Directors

According to the 2025 annual accounts

Solmé Pharma BV

Director · represented by Melissa Sol

since 2014

Shareholders

SOLME PHARMA

93.3%

Participations

Thuizorg Cooperatie

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Benedictusdreef 10

2900 Schoten

2.025.929.231

Eikenlei 13 B

2960 Brecht

Active since 1 January 1985

2.365.132.489

Hogebaan 70

2960 Brecht

Active since 13 November 2024

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Thiers Maria, Vinck Paula en Bequet Anne fv

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.532.853

VAT number

BE 0426.532.853

Registered office

Sint-Benedictusdreef 10, 2900 Schoten

Names & denominations

Apotheek St.-Job

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

11 December 1984

Peppol

Active · Active since 14 May 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek St.-Job

Warning lights

Financials

What happened to Apotheek St.-Job?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions